Join the Cladribine group to help and get support from people like you.
Cladribine News
FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis
March 29, 2019 – The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting...
Further information
Related condition support groups
Hairy Cell Leukemia, Multiple Sclerosis